Pharming Group N.V. (PHAR) News
Follow Pharming Group N.V. (PHAR) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 17 public stories across 11 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Pharming reports positive Phase II topline data for leniolisib
The company presented initial high-level results for leniolisib in genetic primary immunodeficiencies with immune dysregulation at ESID 2026.
EQUITY | Oct 14, 2026, 06:00 AM UTC
L
Pharming announces CEO transition
Leiden, the Netherlands, September 29, 2026: Pharming (Euronext Amsterdam: PHARM/NASDAQ:PHAR), a global biotechnology company focused on rare immune and genetic diseases, today announced that the Board of Directors and F
NEWS | Sep 29, 2026, 05:00 AM UTC
L
Pharming wins FDA Priority Review for Joenja sNDA
Pharming said the U.S. FDA accepted and granted Priority Review to its sNDA for lower doses of Joenja to treat children with APDS.
REGULATION | Sep 25, 2026, 02:30 PM UTC
L
UK's Pharos Energy H1 oil and gas sales rise 30%, net loss narrows
OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feed
EARNINGS | Sep 23, 2026, 06:11 AM UTC
L
Pharos Energy PLC files Form 8.3 disclosure under Takeover Code
Caisse Federale De Credit Mutuel has filed a Rule 8.3 Form 8.3 public opening position disclosure/dealing disclosure for Pharos Energy PLC, covering interests in relevant securities at 1% or more.
MNA | Sep 07, 2026, 02:29 PM UTC
L
PHAROS ENERGY PLC files Form 8.3 disclosure
Caisse Federale De Credit Mutuel has filed a Form 8.3 public opening position dealing disclosure for Pharos Energy PLC under Rule 8.3 of the Takeover Code.
MNA | Sep 04, 2026, 02:29 PM UTC
L
Trium Capital LLP files Form 8.3 on Pharos Energy PLC holdings
Trium Capital LLP has filed a Form 8.3 public opening position disclosure/dealing disclosure under Rule 8.3 of the Takeover Code for Pharos Energy PLC.
MNA | Sep 04, 2026, 02:15 PM UTC
L
Pharos Energy reports major holdings notification TR-1
Pharos Energy PLC filed a TR-1 notification of major holdings, covering an acquisition or disposal of voting rights for a person subject to notification.
MNA | Sep 04, 2026, 10:43 AM UTC
L
Pharos Energy files TR-1 major holdings notification
Pharos Energy PLC filed a TR-1 standard form for notification of major holdings regarding an acquisition or disposal of voting rights.
MNA | Sep 02, 2026, 03:02 PM UTC
L
Oddo BHF AIF PLC files Form 8.3 disclosure for Pharos Energy PLC
Oddo BHF AIF PLC has filed a Form 8.3 public opening position disclosure/dealing disclosure under Rule 8.3 of the Takeover Code for Pharos Energy PLC.
MNA | Sep 02, 2026, 08:09 AM UTC
L
REG - Pharos Energy PLC Ratio Petroleum Enrg - RESULTS OF THE COURT MEETING AND GENERAL MEETING
REG - Pharos Energy PLC Ratio Petroleum Enrg - RESULTS OF THE COURT MEETING AND GENERAL MEETING
EQUITY | Aug 28, 2026, 01:09 PM UTC
L
Pharos Energy PLC: holding(s) in company registration
Registration notice filed for holding(s) in Pharos Energy PLC.
EQUITY | Aug 27, 2026, 12:39 PM UTC
L
Pharos Energy files amended Form 8.3
UBS Financial Services filed an amended Form 8.3 for Pharos Energy PLC, according to a TradingView News alert.
EQUITY | Aug 26, 2026, 01:01 PM UTC
L
REG - Pharos Energy PLC - Holding(s) in Company
REG - Pharos Energy PLC - Holding(s) in Company
EQUITY | Aug 26, 2026, 11:32 AM UTC
L
Pharos Energy PLC files Form 8.3 with Oddo BHF AIF
Oddo BHF AIF PLC has filed a Form 8.3 for Pharos Energy PLC, according to TradingView News.
EQUITY | Aug 26, 2026, 07:31 AM UTC
H
Meta Posts Mixed Q2 Results, Joins Coursera, Qualcomm And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session
U.S. stock futures were higher this morning, with the Dow futures gaining around 0.2% on Thursday. Shares of Meta Platforms Inc (NASDAQ: META ) fell sharply in pre-market trading after the company posted mixed financial
EARNINGS | Jul 30, 2026, 12:03 PM UTC
L
Pharming Lowers FY2026 Sales Guidance from $405.000M-$425.000M to $375.000M-$395.000M vs $419.100M Est
Pharming (NASDAQ: PHAR ) lowers FY2026 sales outlook from $405.000 million-$425.000 million to $375.000 million-$395.000 million vs $419.100 million estimate.
EARNINGS | Jul 30, 2026, 07:49 AM UTC